Dasu Badri N

Avg. Two Year Performance

No purchase track record

64% Avg. Sale Return

28% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	40%	48%	32%	56%	64%
Sale Success Rate	1 of 1	1 of 1	1 of 1	1 of 1	1 of 1

AcelRx Pharmaceuticals, Inc.

Drugs » Drug Manufacturers - Major

Chief Engineering Officer:

Holdings: 31.41K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--